Personalized Models for Cancer Research
NCT06350539 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2025-03-03
Summary
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate cancer research ranging from disease mechanisms to personalized medicine approaches that will help to realize the promise of precision medicine for oncology.
Conditions
- Solid Tumor, Adult
Interventions
- OTHER
-
Biological Sample Collection
Excess/leftover biospecimens that were (or will be) collected for other purposes (e.g., medical procedure).
Sponsors & Collaborators
-
Stevens Institute of Technology
collaborator OTHER -
New York Stem Cell Foundation Research Institute
lead OTHER
Principal Investigators
-
Laura Andres-Martin, PhD · New York Stem Cell Foundation Research Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-02-15
- Primary Completion
- 2034-02-15
- Completion
- 2034-02-15
Countries
- United States
Study Locations
More Related Trials
-
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
NCT05390827 ·Status: RECRUITING
-
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT02178163 ·Status: RECRUITING ·Phase: NA
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection
NCT05585684 ·Status: RECRUITING
-
Data Collection, Clinical Care and Interventions in CCR, NCI
NCT00923065 ·Status: ENROLLING_BY_INVITATION
-
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
NCT02628379 ·Status: COMPLETED
-
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
NCT06744296 ·Status: RECRUITING
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
NCT01109394 ·Status: RECRUITING
-
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
NCT01031056 ·Status: WITHDRAWN
-
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
NCT00230308 ·Status: RECRUITING
-
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 ·Status: RECRUITING
-
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
NCT00026663 ·Status: COMPLETED
-
Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model
NCT02141152 ·Status: COMPLETED
-
Personalized Cancer Care at Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute
NCT03098576 ·Status: COMPLETED
-
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
NCT02215928 ·Status: RECRUITING
-
Collection of Blood Specimens for Circulating Tumor Cell Analysis
NCT01943500 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
NCT01642095 ·Status: WITHDRAWN
-
The Natural History of Solid Organ Cancer Stem Cells (SOCSC)
NCT00923052 ·Status: TERMINATED
-
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
NCT00001503 ·Status: COMPLETED
-
Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies
NCT01802905 ·Status: COMPLETED ·Phase: NA
-
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer
NCT02610218 ·Status: UNKNOWN
-
Registry Study for Personalized Cancer Therapy
NCT02508662 ·Status: COMPLETED
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens
NCT02749838 ·Status: UNKNOWN